The spread of COVID-19 is causing Europe to experience one of the greatest health crises in decades, the consequences of which are still unpredictable. Faced with this unprecedented situation, the governments of different European countries have been forced to issue a series of legislative measures to alleviate the social, economic, administrative, and health effects of the COVID-19 crisis. These circumstances have, among effects on other industry sectors, a significant impact on the pharmaceutical and medical devices' industries. One matter of importance for the public and for manufacturers is the supply of critical products and potential conversion of production.